1ST American Medical Distributors, Inc.

1ST American Medical Distributors, Inc., a service-disabled veteran-owned small business (SDVOSB) headquartered in Murfreesboro, Tennessee, distributes medical equipment and diagnostic imaging devices to federal health agencies as a prime contractor (100% of awards), with a footprint spanning the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and a growing number of defense and civilian medical centers. The company is self-certified as a small disadvantaged business, veteran-owned business, and SDVOSB; it competes predominantly under SDVOSB set-asides and total small business set-asides, with a material share of awards issued without set-aside designation as the vendor has matured its GSA schedule presence.

1ST American Medical Distributors supplies hemodynamic monitoring systems (HemoSphere Advanced Monitoring, Edwards Lifesciences equipment), medical imaging injection systems (Bayer Medrad, MEDRAD Stellant FLEX, Mark 7 Arterion, MRXperion, PET infusion systems), examination chairs and tables (Midmark, barrier-free models, podiatry and procedure variants), ultrasound equipment and tables, sterilization and dose calibration systems, and maintenance and repair services for diagnostic imaging equipment. Representative recent work includes a $2.963 billion delivery order from VA VISN 17 for 41 HemoSphere Alta all-in-one monitoring systems with modules and accessories (June 2026), a $1.124 billion delivery order from VA VISN 8 for Midmark examination tables (March 2024), a $872 thousand delivery order from VA VISN 17 for HemoSphere recovery bundles, covers, and stands (September 2026), a $17.3 million definitive contract from the Defense Health Agency for enterprise dose monitoring maintenance services (September 2025, completing September 2030), and a $365.6 thousand definitive contract from VA VISN 17 for Bayer Medrad injector preventive maintenance services (June 2024, through June 2027).

Customer concentration is extreme and VA-centric. The top five VA VISNs by award count account for 33% of all awards; by potential value, the top five customers (led by VA VISN 12 at $68.6 million, VA VISN 15 at $25.5 million, and VA VISN 17 at $21.9 million) account for 46% of combined potential value. The vast majority of orders flow through VA medical centers and their subordinate command structures, with secondary footprints at the Defense Health Agency, Indian Health Service, National Cancer Institute, and scattered military treatment facilities (Madigan Army Medical Center, Keesler Air Force Base, Naval Medical Center San Diego, William Beaumont Army Medical Center, Travis Air Force Base). This concentration reflects the vendor's primary reliance on the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A) and VA blanket purchase agreements for recurring task order volume.

The vendor holds a flagship $62 million GSA Medical Equipment and Supplies Federal Supply Schedule contract (FSS-65-II-A) awarded in December 2021 through November 2026, which serves as the parent vehicle for 1,311 task orders carrying $108.6 million in combined potential value. The vendor also operates under two single-award indefinite-delivery contracts: one with the Department of Veterans Affairs Veterans Integrated Service Network 23 for Bayer Contrast Injector maintenance services ($827.1 thousand ceiling, May 2026 through April 2029), and one with the Defense Health Agency for maintenance and repair of Bayer Injector Systems at Madigan Army Medical Center ($191.3 thousand ceiling, May 2025 through April 2028). Two blanket purchase agreements with the VA for medical and surgical products and medical imaging supplies round out the vehicle portfolio.

Activity trajectory shows a volatile recent pattern: 113 awards in 2022, 133 in 2023, declining sharply to 62 in 2024, then 38 in 2025, and 50 in the partial year 2026 so far. The vendor faces a modest recompete cliff of 36 awards (combined potential value $5.8 million) completing in the next twenty-four months. The combined potential value footprint of $336.7 million across 2,558 prime awards is substantially larger than the obligated amount ($207.5 million, or 62% of potential value), indicating significant ceiling drawdown and order concentration on a smaller subset of active vehicles.

Service Contract Inventory activity is minimal and immaterial to understanding the vendor's federal posture. SCI-reportable invoicing totaled $336 thousand across FY2023 only, at a median rate of $175.07 per hour, reflecting only one prime contract over the FY2022–FY2025 window; no subcontractors were engaged. The vendor's federal revenue base rests almost entirely on goods procurement (examination chairs, medical devices, injection systems, ultrasound tables, monitoring equipment) and product maintenance services, which fall outside the $150,000 SCI reporting threshold or are classified as goods rather than services. The SCI footprint does not represent the vendor's actual federal services or full enterprise scale.

Since registering in SAM.gov in 2007, the vendor has positioned itself as a direct distributor of manufacturer-brand medical equipment to VA facilities, leveraging SDVOSB set-asides and a single anchor GSA schedule contract to achieve dense penetration in a narrow customer base (VA VISNs 6–23, with VISN 12 and VISN 17 accounting for outsized value). Across the award portfolio, the vendor operates exclusively as a prime contractor with no subcontractor engagement, assembling its own delivery teams and fulfilling orders directly from its Murfreesboro facility and regional performance locations. Growth has decelerated sharply since 2023, and the vendor now faces significant concentration risk around a single parent vehicle (the FSS-65-II-A schedule through November 2026) and a customer base almost entirely contained within the VA health system.

We specialize in medical equipment and products for clinics, hospitals, rehabilitation centers and other healthcare professionals.